Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus fentanyl during cardiac surgery for prevention of chronic thoracic pain
NL-OMON41643Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remifentanil and fentanyl in thoracic pain (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Percentage of patients with chronic thoracic pain at 12 months after cardiac surgery. Started Feb 2014; status: active, not recruiting.
02
Drugs
remifentanilfentanyl
03
Conditions
thoracic pain
Beyond the preview
Go deeper on NL-OMON41643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41643.